Concepedia

Publication | Open Access

<i>CYP2C19</i> -Guided Antiplatelet Therapy: A Cost–Effectiveness Analysis of 30-Day and 1-Year Outcomes Following Percutaneous Coronary Intervention

DOIFull Paper Access

35

Citations

27

References

2017

Year

Mrudula Borse, Olivia M Dong, Melissa J. Polasek, Joel F. Farley, George A. Stouffer, Craig R. Lee
Pharmacogenomics

Abstract

Implementing a CYP2C19 genotype-guided approach to antiplatelet therapy could have a positive economic impact by preventing readmissions following percutaneous coronary intervention.

References

YearCitations

Page 1